NO20082112L - 3-Amino-2-arylpropylazaindoler og deres anvendelse - Google Patents
3-Amino-2-arylpropylazaindoler og deres anvendelseInfo
- Publication number
- NO20082112L NO20082112L NO20082112A NO20082112A NO20082112L NO 20082112 L NO20082112 L NO 20082112L NO 20082112 A NO20082112 A NO 20082112A NO 20082112 A NO20082112 A NO 20082112A NO 20082112 L NO20082112 L NO 20082112L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- arylpropylazaindoles
- amino
- methods
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Abstract
Foreliggende oppfinnelse tilveiebringer forbindelser med formel I: I eller farmasøytisk akseptable salter, solvater eller promedikamenter derav, hvor p, Ar, R1, R2, R3, Ra, Rb, Rc, Rd og Re er definert her. Det tilveiebringes også farmasøytiske preparater, metoder for anvendelse og metoder for fremstilling av forbindelsene. Forbindelsene er anvendelige for behandling av sykdommer forbundet med monoamin-gjenopptakshemmere.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74127205P | 2005-11-30 | 2005-11-30 | |
PCT/EP2006/068650 WO2007062998A1 (en) | 2005-11-30 | 2006-11-20 | 3-amino-2-arylpropyl azaindoles and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082112L true NO20082112L (no) | 2008-06-23 |
Family
ID=37667384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082112A NO20082112L (no) | 2005-11-30 | 2008-05-06 | 3-Amino-2-arylpropylazaindoler og deres anvendelse |
Country Status (17)
Country | Link |
---|---|
US (2) | US7638517B2 (no) |
EP (1) | EP1957488B1 (no) |
JP (1) | JP2009517432A (no) |
KR (1) | KR101026570B1 (no) |
CN (1) | CN101321752A (no) |
AR (1) | AR057188A1 (no) |
AT (1) | ATE442368T1 (no) |
AU (1) | AU2006319233B9 (no) |
BR (1) | BRPI0619184A2 (no) |
CA (1) | CA2632284A1 (no) |
DE (1) | DE602006009138D1 (no) |
ES (1) | ES2329413T3 (no) |
NO (1) | NO20082112L (no) |
RU (1) | RU2008120141A (no) |
TW (1) | TW200804376A (no) |
WO (1) | WO2007062998A1 (no) |
ZA (1) | ZA200804299B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2912744B1 (fr) * | 2007-02-16 | 2012-09-07 | Centre Nat Rech Scient | Composes pyrrolo°2,3-b!pyridine,composes azaindoles utiles dans la synthese de ces composes pyrrolo°2,3-b!pyridine, leurs procedes de fabrication et leurs utilisations. |
US7871802B2 (en) * | 2007-10-31 | 2011-01-18 | E.I. Du Pont De Nemours And Company | Process for enzymatically converting glycolonitrile to glycolic acid |
WO2009148290A2 (en) * | 2008-06-05 | 2009-12-10 | Sk Holdings Co., Ltd. | 3-substituted propanamine compounds |
US8101642B2 (en) | 2008-06-05 | 2012-01-24 | Sk Biopharmaceuticals Co., Ltd. | 3-substituted propanamine compounds |
EP2356116A1 (en) | 2008-11-20 | 2011-08-17 | OSI Pharmaceuticals, Inc. | Substituted pyrroloý2,3-b¨-pyridines and-pyrazines |
US8222416B2 (en) * | 2009-12-14 | 2012-07-17 | Hoffmann-La Roche Inc. | Azaindole glucokinase activators |
JP2013526570A (ja) * | 2010-05-14 | 2013-06-24 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 縮合二環式キナーゼ阻害剤 |
AR081039A1 (es) | 2010-05-14 | 2012-05-30 | Osi Pharmaceuticals Llc | Inhibidores biciclicos fusionados de quinasa |
WO2012158658A1 (en) | 2011-05-16 | 2012-11-22 | OSI Pharmaceuticals, LLC | Fused bicyclic kinase inhibitors |
AR098436A1 (es) * | 2013-11-19 | 2016-05-26 | Actelion Pharmaceuticals Ltd | Compuestos tricíclicos de piperidina |
CN108034283B (zh) * | 2017-12-15 | 2020-10-13 | 淮海工学院 | 一种聚乙二醇化苯并吲哚七甲川菁染料及其制备方法和应用 |
US20220098210A1 (en) * | 2019-01-29 | 2022-03-31 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Quindoline compounds and uses thereof |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE849108C (de) | 1948-10-01 | 1952-09-11 | Hoechst Ag | Verfahren zur Herstellung von 1-disubstituierten 3-Aminopropanen |
GB705652A (en) | 1948-10-01 | 1954-03-17 | Farbewerke Hoechst Ag | Manufacture of 3-aminopropane compounds |
NL82464C (no) | 1952-01-05 | |||
US2708197A (en) | 1952-05-24 | 1955-05-10 | Upjohn Co | Preparation of (hydroxy-3-indole)-alkylamines |
US2984670A (en) | 1959-05-22 | 1961-05-16 | Upjohn Co | Novel 3-(1-hydroxy-1-phenyl-3-aminopropyl) indoles |
GB992731A (en) | 1962-09-28 | 1965-05-19 | Koninklijke Pharma Fab Nv | Aminoalkyl-indolyl-benzyl alcohols |
US4616080A (en) | 1984-07-02 | 1986-10-07 | Eli Lilly And Company | Simplified process of forming crystalline ceftazidime pentahydrate |
KR880007433A (ko) * | 1986-12-22 | 1988-08-27 | 메리 앤 터커 | 3-아릴옥시-3-치환된 프로판아민 |
US4956388A (en) * | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
DE3852551T2 (de) * | 1987-12-11 | 1995-05-18 | Mitsui Petrochemical Ind | Amine und deren verwendung. |
JPH0314562A (ja) | 1988-04-11 | 1991-01-23 | Nippon Chemiphar Co Ltd | 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤 |
US4902710A (en) * | 1988-12-14 | 1990-02-20 | Eli Lilly And Company | Serotonin and norepinephrine uptake inhibitors |
FR2674522B1 (fr) | 1991-03-26 | 1993-07-16 | Lipha | Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant. |
US5177088A (en) | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
US5185350A (en) | 1991-09-23 | 1993-02-09 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles |
EP0600830A1 (de) | 1992-11-27 | 1994-06-08 | Ciba-Geigy Ag | Substituierte Derivate von Diaminophthalimid als Protein-Tyrosin-Kinase-Hemmer |
GB9225141D0 (en) | 1992-12-01 | 1993-01-20 | Smithkline Beecham Corp | Chemical compounds |
GB9518552D0 (en) | 1995-09-11 | 1995-11-08 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
GB9523948D0 (en) | 1995-11-23 | 1996-01-24 | Univ East Anglia | Process for preparing n-benzyl indoles |
JPH09176162A (ja) | 1995-12-22 | 1997-07-08 | Toubishi Yakuhin Kogyo Kk | チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物 |
US6686353B1 (en) | 1996-05-20 | 2004-02-03 | Teijin Intellectual Property Center Limited | Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
EP0912494A1 (en) | 1996-06-07 | 1999-05-06 | Nps Pharmaceuticals, Inc. | Coumpounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
SE9701144D0 (sv) | 1997-03-27 | 1997-03-27 | Pharmacia & Upjohn Ab | Novel compounds, their use and preparation |
EP0887348A1 (en) | 1997-06-25 | 1998-12-30 | Boehringer Mannheim Italia S.p.A. | Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |
JP2001518470A (ja) | 1997-09-26 | 2001-10-16 | メルク エンド カムパニー インコーポレーテッド | 新規な血管形成阻害剤 |
WO1999021557A1 (en) | 1997-10-28 | 1999-05-06 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
WO1999021553A1 (en) | 1997-10-28 | 1999-05-06 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
FR2780890B3 (fr) | 1998-07-10 | 2000-09-01 | Sanofi Sa | Utilisation d'une composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et l'indomethacine pour le traitement des glomerulonephrites chroniques |
ATE355054T1 (de) | 1998-07-13 | 2006-03-15 | Nps Pharma Inc | Verfahren und verbindungen zur behandlung der depression |
SE9903998D0 (sv) | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
FR2814073B1 (fr) | 2000-09-21 | 2005-06-24 | Yang Ji Chemical Company Ltd | Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition |
CA2440037C (en) | 2001-03-05 | 2010-02-16 | Transtech Pharma, Inc. | Benzimidazole derivatives for modulating the rage receptor |
GB0112122D0 (en) * | 2001-05-18 | 2001-07-11 | Lilly Co Eli | Heteroaryloxy 3-substituted propanamines |
CN1589269A (zh) | 2001-10-26 | 2005-03-02 | 康涅狄格大学 | 杂1,2-二氢化茚:一类新型有效的大麻配体 |
AU2002347022A1 (en) | 2001-12-20 | 2003-07-09 | Novo Nordisk A/S | Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten |
AU2002360819A1 (en) | 2001-12-28 | 2003-07-24 | Bayer Corporation | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
US7244847B2 (en) | 2002-02-06 | 2007-07-17 | Isis Pharmaceuticals, Inc. | Benzimidazole compounds |
ATE486842T1 (de) * | 2002-03-12 | 2010-11-15 | Merck Sharp & Dohme | Substituierte amide |
CA2480856A1 (en) * | 2002-04-05 | 2003-10-23 | Merck & Co., Inc. | Substituted aryl amides |
JP4459629B2 (ja) * | 2002-04-12 | 2010-04-28 | メルク エンド カムパニー インコーポレーテッド | 二環式アミド |
DE602004016177D1 (de) | 2003-05-09 | 2008-10-09 | Hoffmann La Roche | Methylindole und methylpyrrolopyridine als alpha-1-adrenerge agonisten |
WO2005005439A1 (en) | 2003-07-09 | 2005-01-20 | Suven Life Sciences Limited | Benzothiazino indoles |
CN1956949A (zh) * | 2003-09-18 | 2007-05-02 | 默克公司 | 取代的磺酰胺 |
AU2004287849A1 (en) * | 2003-10-30 | 2005-05-19 | Merck Sharp & Dohme Corp. | Aralkyl amines as cannabinoid receptor modulators |
US7517899B2 (en) * | 2004-03-30 | 2009-04-14 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
MXPA06014018A (es) | 2004-06-01 | 2007-02-08 | Hoffmann La Roche | 3-amino-1-arilpropil-indoles como inhibidores de reabsorcion de monoaminas. |
BRPI0616459A2 (pt) * | 2005-09-29 | 2011-06-21 | Wyeth Corp | compostos das fórmulas i, ii, e iii; processos para o tratamento ou para a prevenção de: um estado de saúde com melhora devido à recaptação de monoamina; pelo menos um sintoma vasomotor; pelo menos um distúrbio depressivo; pelo menos uma disfunção sexual; para a prevenção de dor; de distúrbio gastrointestinal ou genitourinário; de sìndrome de fadiga crÈnica; de sìndrome de fibromialgia; de esquizofrenia; e uso de um composto |
-
2006
- 2006-11-20 AU AU2006319233A patent/AU2006319233B9/en not_active Ceased
- 2006-11-20 KR KR1020087012919A patent/KR101026570B1/ko not_active IP Right Cessation
- 2006-11-20 DE DE602006009138T patent/DE602006009138D1/de active Active
- 2006-11-20 ES ES06819602T patent/ES2329413T3/es active Active
- 2006-11-20 EP EP06819602A patent/EP1957488B1/en not_active Not-in-force
- 2006-11-20 CA CA002632284A patent/CA2632284A1/en not_active Abandoned
- 2006-11-20 AT AT06819602T patent/ATE442368T1/de active
- 2006-11-20 JP JP2008542715A patent/JP2009517432A/ja active Pending
- 2006-11-20 WO PCT/EP2006/068650 patent/WO2007062998A1/en active Application Filing
- 2006-11-20 RU RU2008120141/04A patent/RU2008120141A/ru not_active Application Discontinuation
- 2006-11-20 BR BRPI0619184-3A patent/BRPI0619184A2/pt not_active IP Right Cessation
- 2006-11-20 CN CNA2006800451404A patent/CN101321752A/zh active Pending
- 2006-11-28 TW TW095143987A patent/TW200804376A/zh unknown
- 2006-11-28 AR ARP060105231A patent/AR057188A1/es unknown
- 2006-11-29 US US11/605,729 patent/US7638517B2/en not_active Expired - Fee Related
-
2008
- 2008-05-06 NO NO20082112A patent/NO20082112L/no not_active Application Discontinuation
- 2008-05-19 ZA ZA200804299A patent/ZA200804299B/xx unknown
-
2009
- 2009-11-16 US US12/619,275 patent/US20100056499A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2329413T3 (es) | 2009-11-25 |
AU2006319233B9 (en) | 2011-09-29 |
TW200804376A (en) | 2008-01-16 |
KR101026570B1 (ko) | 2011-03-31 |
ATE442368T1 (de) | 2009-09-15 |
AR057188A1 (es) | 2007-11-21 |
EP1957488A1 (en) | 2008-08-20 |
ZA200804299B (en) | 2009-04-29 |
EP1957488B1 (en) | 2009-09-09 |
AU2006319233A1 (en) | 2007-06-07 |
CN101321752A (zh) | 2008-12-10 |
KR20080064192A (ko) | 2008-07-08 |
DE602006009138D1 (de) | 2009-10-22 |
RU2008120141A (ru) | 2010-01-10 |
US7638517B2 (en) | 2009-12-29 |
JP2009517432A (ja) | 2009-04-30 |
WO2007062998A1 (en) | 2007-06-07 |
CA2632284A1 (en) | 2007-06-07 |
US20070123535A1 (en) | 2007-05-31 |
BRPI0619184A2 (pt) | 2011-09-13 |
AU2006319233B2 (en) | 2011-06-02 |
US20100056499A1 (en) | 2010-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082112L (no) | 3-Amino-2-arylpropylazaindoler og deres anvendelse | |
NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
NO20081844L (no) | Terapeutiske forbindelser | |
DK2324008T3 (da) | Diarylpyrazol som protein kinase inhibitorer | |
NO20055496D0 (no) | Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer | |
NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
NO20076134L (no) | Benzamidderivater og anvendelser derav | |
NO20063620L (no) | Arylanilinderivater som beta2 adrenergiske receptoragonister | |
NO20064282L (no) | Morfolinforbindelser | |
NO20092033L (no) | Nye forbindelser | |
SG170101A1 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
NO20065880L (no) | 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor | |
ATE512961T1 (de) | Amorphes nebivolol hydrochlorid und seine herstellung | |
TW200833693A (en) | Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors | |
NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
NO20074703L (no) | Antibakterielle piperidinderivater | |
NO20064010L (no) | Indazolderivater og farmasoytiske preparater inneholdelse slike | |
DK2054418T3 (da) | Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer | |
NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
NO20062453L (no) | Tiozolidinoner, fremstilling og anvendelse derav som legemidler | |
TW200639156A (en) | New compounds | |
SE0401342D0 (sv) | Therapeutic compounds | |
NO20092058L (no) | Heteroaryl pyrrolidinyl ketonderivater | |
NO20065873L (no) | 3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |